Advancing bladder preservation: Biomarkers, decision-making, and therapy
McConkey, D., C. J. M. Best, J. A. Gumminger, and A. F. Olumi. 2021. Advancing Bladder Preservation: Biomarkers, Decision-Making, and Therapy.
Search
Search results
116 results found
The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillance
Monfared, S., A. Fleishman, R. Korets, P. Chang, A. Wagner, G. Bubley, I. Kaplan, A. F. Olumi, and B. Gershman. 2021. The Impact of Pretreatment PSA on Risk Stratification in Men With Gleason 6 Prostate Cancer: Implications for Active Surveillance.
Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder
Bharadwaj, M., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, S. Kim, et al. 2022. Adjuvant Chemotherapy versus Observation Following Radical Cystectomy for Locally Advanced Urothelial Carcinoma of the Bladder.
Adjuvant Chemotherapy Plus Radiotherapy versus Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical Cystectomy
Ernandez, J., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, S. Kim, et al. 2022. Adjuvant Chemotherapy Plus Radiotherapy versus Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy.
Single black men have the worst prognosis with localized prostate cancer
Liu, S., Z. Wang, X. Long, A. Fleishman, X. Huang, Q. Wu, B. Gershman, and A. F. Olumi. 2022. Single Black Men Have the Worst Prognosis With Localized Prostate Cancer.
Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis
Gulati, R., B. Jiao, R. Al-Faouri, V. Sharma, S. Kaul, A. Fleishman, K. Wymer, et al. 2024. Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging As First-Line Screening for Prostate Cancer : A Decision Model Analysis.
Predicting cancer detection rates from multiparametric prostate MRI Beyond the PI-RADS classification system
Perez-Londono, A., F. Ramos, A. Fleishman, S. Kaul, R. Korets, M. Johnson, A. F. Olumi, L. Tsai, and B. Gershman. 2025. Predicting Cancer Detection Rates from Multiparametric Prostate MRI Beyond the PI-RADS Classification System.
Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy
San Francisco, I. F., W. C. DeWolf, S. Rosen, M. Upton, and A. F. Olumi. 2003. Extended Prostate Needle Biopsy Improves Concordance of Gleason Grading Between Prostate Needle Biopsy and Radical Prostatectomy.
Pathologic quiz case. A symptomatic renal tumor. Juxtaglomerular cell tumor
Kuten, A., A. Olumi, J. Goldsmith, R. A. Monahan-Earley, A. M. Dvorak, and E. M. Genega. 2004. Pathologic Quiz Case. A Symptomatic Renal Tumor. Juxtaglomerular Cell Tumor.
Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen
San Francisco, I. F., M. M. Regan, A. F. Olumi, and W. C. DeWolf. 2004. Percent of Cores Positive for Cancer Is a Better Preoperative Predictor of Cancer Recurrence After Radical Prostatectomy Than Prostate Specific Antigen.